Camkii controls neuromodulation via neuropeptide gene expression and axonal targeting of neuropeptide vesicles

Alessandro Moro, Geeske M.Van Woerden, Ruud F. Toonen, Matthijs Verhage

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)

Abstract

Ca2+/calmodulin-dependent kinase II (CaMKII) regulates synaptic plasticity in multiple ways, supposedly including the secretion of neuromodulators like brain-derived neurotrophic factor (BDNF). Here, we show that neuromodulator secretion is indeed reduced in mouse α- A nd βCaMKII-deficient (αβCaMKII double-knockout [DKO]) hippocampal neurons. However, this was not due to reduced secretion efficiency or neuromodulator vesicle transport but to 40% reduced neuromodulator levels at synapses and 50% reduced delivery of new neuromodulator vesicles to axons. αβCaMKII depletion drastically reduced neuromodulator expression. Blocking BDNF secretion or BDNF scavenging in wild-type neurons produced a similar reduction. Reduced neuromodulator expression in αβCaMKII DKO neurons was restored by active βCaMKII but not inactive βCaMKII or αCaMKII, and by CaMKII downstream effectors that promote cAMP-response element binding protein (CREB) phosphorylation. These data indicate that CaMKII regulates neuromodulation in a feedback loop coupling neuromodulator secretion to βCaMKII- A nd CREB-dependent neuromodulator expression and axonal targeting, but CaMKIIs are dispensable for the secretion process itself.

Original languageEnglish
Article numbere3000826
Pages (from-to)1-30
Number of pages30
JournalPLoS Biology
Volume18
Issue number8 August
Early online date10 Aug 2020
DOIs
Publication statusPublished - Aug 2020

Cite this